Magenta Therapeutics Inc. (MGTA)

AI Score

Unlock

0.70

-0.06 (-7.69%)

At close: Sep 11, 2023, 8:00 PM

Magenta Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-15.76M	-7.38M	3.88M	-21.73M	-17.25M	-18.08M	-23.83M	-20.14M	-18.25M	-17.61M	-18.7M	-19.07M	-18.38M	-20.01M	-21.24M	-24.64M	-22.64M	-19.34M	-16.35M	-17.93M	-16.7M	-14.03M	-11.31M	-8.17M	-7.01M	-15.73M	-4.81M
Interest Income	1.03M	4.09M	2.96M	n/a	1.19M	812K	884K	848K	818K	n/a	1.21M	897K	703K	933K	1.23M	n/a	n/a	n/a	1.52M	1.25M	687K	365K	145K	134K	102K	n/a	n/a
Pretax Income	-14.76M	-3.28M	-29.17M	-20.18M	-16.06M	-17.27M	-22.95M	-19.29M	-17.43M	-16.93M	-17.49M	-18.17M	-17.68M	-19.08M	-20.01M	-23.24M	-20.99M	-17.71M	-14.83M	-16.68M	-16.02M	-13.66M	-11.16M	-8.04M	-6.91M	-15.73M	-4.81M
Net Income	-14.76M	-3.28M	-26.21M	-23.06M	-17.25M	-17.27M	-22.95M	-19.29M	-17.43M	-16.93M	-17.49M	-18.17M	-17.68M	-19.08M	-20.01M	-23.24M	-20.99M	-17.71M	-14.83M	-16.68M	-16.02M	-13.66M	-11.16M	-8.04M	-6.91M	-15.73M	-4.81M
Selling & General & Admin	8.72M	5.32M	6.13M	5.94M	6.05M	6.48M	7.29M	7.03M	7.45M	6.48M	6.97M	6.81M	6.59M	7.4M	7.28M	5.92M	6.12M	5.91M	5.81M	5.54M	5.28M	4.34M	3.46M	2.62M	1.8M	1.92M	1.49M
Research & Development	7.96M	139K	8M	15.79M	11.2M	11.6M	16.55M	13.11M	10.79M	11.13M	11.73M	12.26M	11.79M	12.61M	13.96M	18.71M	16.52M	13.43M	10.54M	12.39M	11.42M	9.68M	7.85M	5.55M	5.21M	13.82M	3.32M
Other Expenses	n/a	1.92M	18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	16.68M	5.46M	14.13M	21.73M	17.25M	18.08M	23.83M	20.14M	18.25M	17.61M	18.7M	19.07M	18.38M	20.01M	21.24M	24.64M	22.64M	19.34M	16.35M	17.93M	16.7M	14.03M	11.31M	8.17M	7.01M	15.73M	4.81M
Interest Expense	n/a	n/a	n/a	n/a	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	16.68M	5.46M	14.13M	21.73M	17.25M	18.08M	23.83M	20.14M	18.25M	17.61M	18.7M	19.07M	18.38M	20.01M	21.24M	24.64M	22.64M	19.34M	16.35M	17.93M	16.7M	14.03M	11.31M	8.17M	7.01M	15.73M	4.81M
Income Tax Expense	n/a	-6.01M	-2.96M	2.89M	1.19M	222K	n/a	-535K	n/a	n/a	n/a	-495K	n/a	n/a	n/a	-485K	n/a	n/a	n/a	-359K	n/a	n/a	n/a	236K	n/a	n/a	n/a
Shares Outstanding (Basic)	3.91M	3.19M	3.19M	3.12M	3.12M	58.82M	58.8M	58.79M	58.58M	53.71M	48.57M	48.35M	48.26M	39.61M	39.36M	39.07M	38.82M	36.66M	33.42M	33.2M	33M	4.39M	34.37M	21.5M	21.5M	21.5M	21.5M
Shares Outstanding (Diluted)	3.91M	3.19M	3.19M	3.12M	3.12M	58.82M	58.8M	58.79M	58.58M	53.71M	48.57M	48.35M	48.26M	39.61M	39.36M	39.07M	38.82M	36.66M	33.42M	33.2M	33M	4.39M	34.37M	21.5M	21.5M	21.5M	21.5M
EPS (Basic)	-3.78	-1.03	-8.21	-7.38	-5.53	-0.29	-0.39	-0.33	-0.3	-0.32	-0.36	-0.38	-0.37	-0.48	-0.51	-0.59	-0.54	-0.48	-0.44	-0.5	-0.49	-3.11	-0.32	-0.37	-0.32	-0.73	-0.22
EPS (Diluted)	-3.78	-1.03	-8.21	-7.38	-5.53	-0.29	-0.39	-0.33	-0.3	-0.32	-0.36	-0.38	-0.37	-0.48	-0.51	-0.59	-0.54	-0.48	-0.44	-0.5	-0.49	-3.11	-0.32	-0.37	-0.32	-0.73	-0.22
EBITDA	-15.76M	-3.54M	4.3M	-21.27M	-16.78M	-18.08M	-22.62M	-20.14M	-17.71M	-17.13M	-18.22M	-19.07M	-17.89M	-19.52M	-20.75M	-24.64M	-22.16M	-18.89M	-15.93M	-17.93M	-16.49M	-13.87M	-11.16M	-7.8M	-6.9M	-15.63M	-4.78M
EBIT	n/a	n/a	n/a	-23.06M	-14.87M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	-39.59K	3.84M	421K	466K	471K	-222K	1.21M	535K	532K	479K	474K	495K	495K	495K	493K	485K	483K	452K	423K	359K	209K	160K	147K	129K	118K	96K	33K